Media collection about conflicts of interest in systematic reviews of neuraminidase inhibitors

As usual, I'm keeping a record of major stories in the media related to a recently published paper. I will continue to update this post to reflect the media response to our article in the Annals of Internal Medicine. Michael McCarthy from the BMJ covered the research, including asking extra questions. Melissa Davey from Guardian covered … Continue reading Media collection about conflicts of interest in systematic reviews of neuraminidase inhibitors

Introducing evidence surveillance as a research stream

I've taken a little while to get this post done because I've been waiting for my recently-published article to go from online-first to being citeable with volume and page numbers. Last year, I was asked to write an editorial on the topic of industry influence on clinical evidence for the Journal of Epidemiology & Community Health, … Continue reading Introducing evidence surveillance as a research stream

Dealing with industry’s influence on clinical evidence

I co-wrote a piece for The Conversation about a new article that was published in the Cochrane Database of Systematic Reviews, written by Andreas Lundh and other luminaries from the research area. The authors showed that industry sponsored clinical trials more often report positive outcomes and fewer harmful side effects. The most interesting result from … Continue reading Dealing with industry’s influence on clinical evidence